- Thursday, September 4, 2014 at the 9 th Annual Citi Biotech Conference in Boston at 10 a.m. ET
- Tuesday, September 9, 2014 at the Morgan Stanley Global Healthcare Conference in New York at 12:55 p.m. ET
Driving sector performance are a recent series of mergers and acquisitions, including Horizon Pharma's purchase of Raptor Pharmaceutical Corp. Then there's the political boost...
The market is fearful. Use that fear to buy, Cramer says.
Hedge fund billionaire Dan Loeb owns a greater than 17% stake in the newly public developer of a drugs including those for treatment of psoriasis.